Nemifitide diTFA

Nootropic / cognitive

Cognition, mood, neuroprotection, or neuroplasticity support

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Nootropic / neuroactive compound
Primary mechanism: Neurotransmitter, neurotrophic, or plasticity pathway modulation
Primary market use: Nootropic / cognitive

Pharmacology

Molecular weight (Da): 922.80
Oral bioavailability: Route-dependent / verify
Half-life: ~5–60 min parent peptide; analogs may be longer
Route tags: SubQ; Injectable; route-dependent
Evidence level: MCE product listing / research chemical signal
Clinical status: Research chemical/reference listing
Value-for-money score: 7 / 10

Reported protocol signal

No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Stackability

Place in nootropic comparison clusters; track acute vs durable cognitive adaptation.

Notes

Nemifitide diTFA (INN 00835 diTFA) is a synthetic pentapeptide antidepressant with a potential for rapid onset of action. Nemifitide diTFA is a peptide analog of melanocyte-inhibiting factor (MIF). Nemifitide diTFA can cross the blood-brain barrier.

Sources

https://www.medchemexpress.com/nemifitide-ditfa.html